Key facts
- It has raised $16.9M; the latest was Early Stage VC in Mar 2026.
- Notable investors include Plum Ventures, Hongtai Capital Holdings, Changxing Fund, Beijing Future Science City Development Group, Qihang Capital — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Yuequan Bionics
- ·The full record, as it builds
Funding rounds
No funding rounds for Yuequan Bionics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Yuequan Bionics
Developer of bionic technology systems created to serve human needs and promote advanced robotic applications. The company offers biomimetic structural design, adaptive mechanical components, sensor-driven control frameworks, and simulation-based testing environments with advanced material applications, enabling scientific and industrial markets to achieve improved functional replication, enhanced experimental accuracy, scalable deployment, reliable performance, and efficient adaptation of biological principles into engineered solutions across diverse technological domains.
- Sector
- Information Technology
- HQ
- Beijing, China
- Founded
- 2022
- Website
- yqbionics.com/
- Ownership
- Privately Held (backing)
Yuequan Bionics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Yuequan Bionics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Yuequan Bionics in its N-PORT filings yet. We sweep new filings monthly.